K/I/E Trust Under Agreement 10 Sells 10,518 Shares of NationalResearchCorp . (NRC) Stock

NationalResearchCorp . (NYSE:NRC) major shareholder K/I/E Trust Under Agreement 10 sold 10,518 shares of the business’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $40.00, for a total value of $420,720.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

K/I/E Trust Under Agreement 10 also recently made the following trade(s):

  • On Thursday, March 14th, K/I/E Trust Under Agreement 10 sold 6,663 shares of NationalResearchCorp . stock. The stock was sold at an average price of $40.00, for a total value of $266,520.00.
  • On Wednesday, February 20th, K/I/E Trust Under Agreement 10 sold 89,025 shares of NationalResearchCorp . stock. The stock was sold at an average price of $40.01, for a total value of $3,561,890.25.
  • On Friday, February 15th, K/I/E Trust Under Agreement 10 sold 11,848 shares of NationalResearchCorp . stock. The stock was sold at an average price of $40.04, for a total value of $474,393.92.
  • On Thursday, January 31st, K/I/E Trust Under Agreement 10 sold 2,073 shares of NationalResearchCorp . stock. The stock was sold at an average price of $40.01, for a total value of $82,940.73.
  • On Friday, January 25th, K/I/E Trust Under Agreement 10 sold 9,730 shares of NationalResearchCorp . stock. The stock was sold at an average price of $40.01, for a total value of $389,297.30.

NRC stock opened at $39.00 on Friday. NationalResearchCorp . has a 1-year low of $28.35 and a 1-year high of $42.85.

NationalResearchCorp . (NYSE:NRC) last posted its quarterly earnings results on Tuesday, February 12th. The company reported $0.30 earnings per share for the quarter. The business had revenue of $30.64 million during the quarter.

The company also recently announced a quarterly dividend, which will be paid on Monday, April 15th. Stockholders of record on Friday, March 29th will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Thursday, March 28th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.95%.

Several hedge funds and other institutional investors have recently bought and sold shares of NRC. Dimensional Fund Advisors LP raised its holdings in NationalResearchCorp . by 0.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 733,832 shares of the company’s stock valued at $27,989,000 after buying an additional 3,622 shares during the period. Legal & General Group Plc increased its stake in NationalResearchCorp . by 35.0% in the fourth quarter. Legal & General Group Plc now owns 2,118 shares of the company’s stock worth $81,000 after purchasing an additional 549 shares during the period. Metropolitan Life Insurance Co. NY grew its position in shares of NationalResearchCorp . by 354.8% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 3,511 shares of the company’s stock worth $134,000 after buying an additional 2,739 shares in the last quarter. Bank of America Corp DE grew its position in shares of NationalResearchCorp . by 33.7% during the 4th quarter. Bank of America Corp DE now owns 15,386 shares of the company’s stock worth $587,000 after buying an additional 3,882 shares in the last quarter. Finally, Citigroup Inc. grew its position in shares of NationalResearchCorp . by 17.1% during the 4th quarter. Citigroup Inc. now owns 3,342 shares of the company’s stock worth $127,000 after buying an additional 489 shares in the last quarter.

TRADEMARK VIOLATION WARNING: This news story was first published by Stock Observer and is the sole property of of Stock Observer. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.thestockobserver.com/2019/03/15/k-i-e-trust-under-agreement-10-sells-10518-shares-of-nationalresearchcorp-nrc-stock.html.

About NationalResearchCorp .

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.

Recommended Story: How to interpret a stock’s beta number

Insider Buying and Selling by Quarter for NationalResearchCorp   . (NYSE:NRC)

Receive News & Ratings for NationalResearchCorp . Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NationalResearchCorp . and related companies with MarketBeat.com's FREE daily email newsletter.